Blood ApS: Financial statements 2022
CVR: 37650978
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Blood ApS (CVR 37650978) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -3,900 and a net result of DKK -3,623 compared with DKK 246,229 the year before. Equity in the 2022 report amounted to DKK 130,220. The solvency ratio was 98.8%.
- Gross Profit
- DKK -3,900
- Profit/Loss
- DKK -3,623
- Equity
- DKK 130,220
- Total Assets
- DKK 131,820
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -4 t. | -4 t. | 130 t. | 0 |
| 2021 | - | -2 t. | 246 t. | 248 t. | 0 |
| 2020 | - | -2 t. | 62 t. | 115 t. | 0 |
| 2019 | - | -3 t. | 300 t. | 163 t. | 0 |
| 2018 | - | -1 t. | -282 | 41 t. | - |
Official annual report
Keep an eye on Blood ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Blood ApS has published its annual report for 2021. Gross profit came to DKK -2,380, and the net result was DKK 246,229.
About Blood ApS
Blood ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mikkel Nissen Jersin. The company is owned by Mikkel Nissen Jersin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,778 and a net result of DKK 142,452 compared with DKK -7,047 the year before. Equity in the 2025 report amounted to DKK 69,264.